Abstract
An in vitro autophosphorylation assay has been used to demonstrate that there is considerable variation in met associated protein kinase among human tumour cell lines. Of particular note was the very high level of autophosphorylation of the 140 kD met protein (p140met) in experiments with A431 human cervical carcinoma cells. In contrast in experiments with Daoy human medulloblastoma cells we failed to detect phosphorylation of p140met; instead a high level of phosphorylation of a 132 kD protein was observed. To help understand the basis for the variation in kinase activity and to learn more about the structure of the mature met protein we have analysed p140met in SDS-polyacrylamide gels under non-reducing conditions. Under these conditions the met protein had an apparent molecular weight of 165,000 indicating that the mature met protein may exist as an alpha beta complex in which p140met (designated the beta subunit) is joined by disulphide bonds to a smaller, 25 kD, alpha-chain. We have identified a potential proteolytic cleavage site with the sequence Lys-Arg-Lys-Lys-Arg-Ser at amino acids 303-308 in the human met protein that may account for cleavage of the met protein into alpha and beta subunits.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tempest, P., Stratton, M. & Cooper, C. Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. Br J Cancer 58, 3–7 (1988). https://doi.org/10.1038/bjc.1988.150
Issue Date:
DOI: https://doi.org/10.1038/bjc.1988.150
This article is cited by
-
Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation
Oncogene (2019)
-
Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression
Clinical Epigenetics (2017)
-
Progress of antibody-based inhibitors of the HGF–cMET axis in cancer therapy
Experimental & Molecular Medicine (2017)
-
Identification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular protein
Acta Neuropathologica (2015)
-
Tyrosine kinase receptor indistinguishable from the c-met protein
Nature (1989)